These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23175427)

  • 1. Intermediate- and low-methylation epigenotypes do not correspond to CpG island methylator phenotype (low and -zero) in colorectal cancer.
    Karpinski P; Walter M; Szmida E; Ramsey D; Misiak B; Kozlowska J; Bebenek M; Grzebieniak Z; Blin N; Laczmanski L; Sasiadek MM
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):201-8. PubMed ID: 23175427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two groups of DNA methylation markers to classify colorectal cancer into three epigenotypes.
    Kaneda A; Yagi K
    Cancer Sci; 2011 Jan; 102(1):18-24. PubMed ID: 21159060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
    Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
    Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation epigenotype and clinical features of NRAS-mutation(+) colorectal cancer.
    Takane K; Akagi K; Fukuyo M; Yagi K; Takayama T; Kaneda A
    Cancer Med; 2017 May; 6(5):1023-1035. PubMed ID: 28378457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three DNA methylation epigenotypes in human colorectal cancer.
    Yagi K; Akagi K; Hayashi H; Nagae G; Tsuji S; Isagawa T; Midorikawa Y; Nishimura Y; Sakamoto H; Seto Y; Aburatani H; Kaneda A
    Clin Cancer Res; 2010 Jan; 16(1):21-33. PubMed ID: 20028768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
    Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR
    Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
    Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
    Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristic methylation profile in CpG island methylator phenotype-negative distal colorectal cancers.
    An B; Kondo Y; Okamoto Y; Shinjo K; Kanemitsu Y; Komori K; Hirai T; Sawaki A; Tajika M; Nakamura T; Yamao K; Yatabe Y; Fujii M; Murakami H; Osada H; Tani T; Matsuo K; Shen L; Issa JP; Sekido Y
    Int J Cancer; 2010 Nov; 127(9):2095-105. PubMed ID: 20131317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of three epigenotypes in colorectal cancer by combined bisulfite restriction analysis.
    Karpinski P; Szmida E; Misiak B; Ramsey D; Leszczynski P; Bebenek M; Sedziak T; Grzebieniak Z; Jonkisz A; Lebioda A; Sasiadek MM
    Mol Carcinog; 2012 Dec; 51(12):1003-8. PubMed ID: 22006538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer.
    Ichimura N; Shinjo K; An B; Shimizu Y; Yamao K; Ohka F; Katsushima K; Hatanaka A; Tojo M; Yamamoto E; Suzuki H; Ueda M; Kondo Y
    Cancer Prev Res (Phila); 2015 Aug; 8(8):702-11. PubMed ID: 26063725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.
    McInnes T; Zou D; Rao DS; Munro FM; Phillips VL; McCall JL; Black MA; Reeve AE; Guilford PJ
    BMC Cancer; 2017 Mar; 17(1):228. PubMed ID: 28351398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The topography of DNA methylation in the non-neoplastic colonic mucosa surrounding colorectal cancers.
    Subramaniam MM; Loh M; Chan JY; Liem N; Lim PL; Peng YW; Lim XY; Yeoh KG; Iacopetta B; Soong R; Salto-Tellez M
    Mol Carcinog; 2014 Feb; 53(2):98-108. PubMed ID: 22911899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer.
    Worthley DL; Whitehall VL; Buttenshaw RL; Irahara N; Greco SA; Ramsnes I; Mallitt KA; Le Leu RK; Winter J; Hu Y; Ogino S; Young GP; Leggett BA
    Oncogene; 2010 Mar; 29(11):1653-62. PubMed ID: 19966864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile.
    Ferracin M; Gafà R; Miotto E; Veronese A; Pultrone C; Sabbioni S; Lanza G; Negrini M
    J Pathol; 2008 Apr; 214(5):594-602. PubMed ID: 18241079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.
    Lee S; Oh T; Chung H; Rha S; Kim C; Moon Y; Hoehn BD; Jeong D; Lee S; Kim N; Park C; Yoo M; An S
    Int J Oncol; 2012 Mar; 40(3):889-98. PubMed ID: 22038115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
    Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
    Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype.
    Suzuki H; Igarashi S; Nojima M; Maruyama R; Yamamoto E; Kai M; Akashi H; Watanabe Y; Yamamoto H; Sasaki Y; Itoh F; Imai K; Sugai T; Shen L; Issa JP; Shinomura Y; Tokino T; Toyota M
    Carcinogenesis; 2010 Mar; 31(3):342-9. PubMed ID: 19638426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative Analysis of DNA Methylation and Gene Expression Profiles Identifies Colorectal Cancer-Related Diagnostic Biomarkers.
    Xu M; Yuan L; Wang Y; Chen S; Zhang L; Zhang X
    Pathol Oncol Res; 2021; 27():1609784. PubMed ID: 34366718
    [No Abstract]   [Full Text] [Related]  

  • 19. Aberrant DNA methylation patterns in microsatellite stable human colorectal cancers define a new marker panel for the CpG island methylator phenotype.
    Gebhard C; Mulet-Lazaro R; Glatz D; Schwarzfischer-Pfeilschifter L; Schirmacher P; Gaedcke J; Weichert W; Reuschel E; Dietmaier W; Rehli M
    Int J Cancer; 2022 Feb; 150(4):617-625. PubMed ID: 34591983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer.
    Frazier ML; Xi L; Zong J; Viscofsky N; Rashid A; Wu EF; Lynch PM; Amos CI; Issa JP
    Cancer Res; 2003 Aug; 63(16):4805-8. PubMed ID: 12941799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.